Tetramic Acids as Scaffolds:
Synthesis, Tautomeric and Antibacterial Behaviour

Yong-Chul Jeong; Mark G. Moloney

doi:10.1055/s-0029-1217745

LETTER

Tetramic Acids as Scaffolds: Synthesis, Tautomeric and Antibacterial Behaviour

Yong-Chul Jeong, Mark G. Moloney*
Chemistry Research Laboratory, University of Oxford, Mansfield Road, OX1 3TA, UK
Fax: +44(1865)275002; e-Mail: mark.moloney@chem.ox.ac.uk;

Abstract

All articles of this category

Abstract

Efficient synthetic routes for tetramic acids variously substituted on the ring nitrogen, their tautomeric behaviour in solution and their antibiotic activity are reported.

Key words

heterocycles - tautomerism - natural products - drugs

Full Text

References

1a Gänzle MG. Appl. Microbiol. Biotechnol. 2004, 64: 326

1b Sadar MD. Williams DE. Mawji NR. Patrick BO. Wikanta T. Chasanah E. Irianto HE. Soest RV. Andersen RJ. Org. Lett. 2008, 10: 4947

1c Pattenden G. Rescourio G. Org. Biomol. Chem. 2008, 6: 3428

1d Bagwell CL. Moloney MG. Thompson AL. Bioorg. Med. Chem. Lett. 2008, 18: 4081

1e Moloney MG. Trippier PC. Yaqoob M. Wang Z. Curr. Drug Discovery Technol. 2004, 1: 181

1f Jeong Y.-C. Hwang SK. Ahn K.-H. Bull. Korean Chem. Soc. 2005, 26: 826

1g Giordano A. Monica CD. Landi F. Spinella A. Sodano G. Tetrahedron Lett. 2000, 41: 3979

2a Royles BJL. Chem. Rev. 1995, 95: 1981

2b Schobert R. Schlenk A. Bioorg. Med. Chem. 2008, 16: 4203

3a Mulholland TPC. Foster R. Haydock DB. J. Chem. Soc., Perkin Trans. 1 1972, 2121

3b Lowe G. Yeung HW. J. Chem. Soc., Perkin Trans. 1 1973, 2907

3c Heinicke GW. Morella AM. Orban J. Prager RH. Ward AD. Aust. J. Chem. 1985, 38: 1847

3d Page PCB. Hamza AS. Leach DC. Allin SM. Andrews DM. Rassias GA. Org. Lett. 2003, 5: 353

3e Park TH. Paik S. Lee SH. Bull. Korean Chem. Soc. 2003, 24: 1227

3f Spatz JH. Welsch SJ. Duhaut D.-E. Jäger N. Boursier T. Fredrich M. Allmendinger L. Ross G. Kolb J. Burdack C. Umkehrer M. Tetrahedron Lett. 2009, 50: 1705

3g Andrews MD. Brewster A. Moloney MG. Tetrahedron: Asymmetry 1994, 5: 1477

3h Andrews MD. Brewster AG. Crapnell KM. Ibbett AJ. Jones T. Moloney MG. Prout K. Watkin D. J. Chem. Soc., Perkin Trans. 1 1998, 223

3i Jones RCF. Begley MJ. Peterson GE. Sumaria S. J. Chem. Soc., Perkin Trans. 1 1990, 1959

4a Marquardt U. Schmid D. Jung G. Synlett 2000, 1131

4b Li W.-R. Lin ST. Hsu N.-M. Chern M.-S. J. Org. Chem. 2002, 67: 4702

4c Hosseini M. Kringelum H. Myrray A. Tønder JE. Org. Lett. 2006, 8: 2103

4d Pirc S. Bevk D. Jakše R. Rečnik S. Golič L. Golobič A. Meden A. Stanovnik B. Svete J. Synthesis 2005, 2969

4e Liu Z. Ruan X. Huang X. Bioorg. Med. Chem. Lett. 2003, 13: 2505

5a Schobert R. Dietrich M. Mullen G. Urbina-Gonzalez J.-M. Synthesis 2006, 3902

5b Fustero S. Torre MG. Sanz-Cervera JF. Arellano CR. Piera J. Simon A. Org. Lett. 2002, 4: 3651

6a Lacey RN. J. Chem. Soc. 1954, 850

6b Harris SA. Fisher LV. Folkers K. J. Med. Chem. 1965, 8: 478

6c Yuki H. Tohira Y. Aoki B. Kano T. Takama S. Yamazaki T. Chem. Pharm. Bull. 1967, 15: 1107

6d Romoff TT. Ma L. Wang Y. Campbell DA. Synlett 1998, 1341

6e Jones RCF. Pillainayagam TA. Synlett 2004, 2815

6f Steyn PS. Wessels PL. Tetrahedron Lett. 1978, 4707

6g Yendapally R. Hurdle JG. Carson EI. Lee RB. Lee RE. J. Med. Chem. 2008, 51: 1487

7a Baldwin JE. Coates JB. Halpern JB. Moloney MG. Pratt AJ. Biochem. J. 1989, 261: 197

7b Baldwin JE. Coates JB. Moloney MG. Pratt AJ. Willis AC. Biochem. J. 1989, 266: 561

7c Miller AK. Celozzi E. Pelak BA. Stapley EO. Hendlin D. Antimicrob. Agents Chemother. 1972, 2: 281

8a Burmeister HR. Ellis JJ. Hesseltine CW. Appl. Microbiol. 1972, 23: 1165

8b Burmeister HR. Bennett GA. Vesonder RF. Hesseltine CW. Antimicrob. Agents Chemother. 1974, 5: 634

Supplementary Material

Supporting Information